Melatonin Mitigates Sleep Restriction-Induced Cognitive and Glymphatic Dysfunction Via Aquaporin-4 Polarization.
Level 5 - mechanism / opinion, no new human data
Animal/laboratory research with no human data
PubMed 40293704 · doi:10.1007/s12035-025-04992-5
What was done
Researchers evaluated the effect of chronic sleep restriction (SR) and subsequent melatonin administration using a modified rotating rod mouse model. They assessed hippocampal aquaporin-4 (AQP4) localization, short-term memory deficits, and cerebrospinal fluid glymphatic tracer transport across dose-response melatonin regimens. Hippocampal amyloid-beta, phosphorylated tau, glial cell activation, pro-inflammatory cytokines, and synaptic proteins were measured in wild-type and AQP4-knockout mice. Mechanistic pathways involving the vitamin D receptor and dystrobrevin alpha (DTNA) were also analyzed.
What was found
The abstract reports directional findings without numerical values. Chronic sleep restriction induced time-dependent short-term memory deficits and AQP4 mislocalization in the hippocampus. Melatonin treatment dose-dependently improved cognitive function, restored AQP4 polarity, enhanced glymphatic transport, and reduced amyloid-beta, phosphorylated tau, glial activation, pro-inflammatory cytokines, and synaptic protein loss. In AQP4-knockout mice, these protective effects were largely abolished. Melatonin activated the vitamin D receptor and upregulated DTNA, which restored AQP4 polarization.
Why it matters
This study defines an AQP4-dependent mechanism through which melatonin mitigates sleep restriction-induced cognitive deficits and toxic protein accumulation in a rodent model.
Limits
The study was conducted entirely in mice, so translational relevance to human sleep restriction remains unproven. The abstract provides no exact sample sizes, quantitative measurements, or confidence intervals.